方法对比

	前瞻性IV期研究	随机对照试验 (RCT)
领域	流行病学	流行病学
方法族	Process / pipeline	Process / pipeline
起源年份	1970s–1980s (formalized in post-marketing regulatory frameworks)	1948 (first rigorously conducted RCT — MRC streptomycin trial)
提出者	Regulatory and pharmaceutical research community (ICH E2E, EMA PASS guidelines)	Austin Bradford Hill; MRC Streptomycin Trial team
类型	Observational / interventional post-marketing study design	Interventional experimental study
开创性文献	Strom, B.L. (Ed.). (2005). Pharmacoepidemiology (4th ed.). Wiley. ISBN: 978-0470863088	Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
别名	prospective post-marketing surveillance study, prospective pharmacovigilance study, prospective post-authorization safety study, PASS (prospective)	RCT, randomized controlled trial, randomised controlled trial, clinical randomized trial
相关	5	6
摘要	A prospective Phase IV study is a post-marketing investigation conducted after a drug, device, or intervention has received regulatory approval, following participants forward in real time to collect safety, effectiveness, and utilization data under routine clinical practice conditions. Unlike retrospective designs that mine existing records, prospective enrollment allows pre-specified data collection, defined follow-up windows, and direct measurement of outcomes as they occur, making it central to post-authorization safety surveillance and long-term effectiveness research.	A randomized clinical trial (RCT) is an experimental study design in which participants are randomly assigned to an intervention group or a control group, then followed prospectively to compare outcomes. Random allocation is the defining feature: it distributes known and unknown confounders across groups by chance, making the RCT the strongest individual study design for establishing causal efficacy of a treatment or intervention under controlled conditions.